Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1310221
European Journal of Endocrinology, Vol 131, Issue 3, 221-228
Copyright © 1994 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, J.
Right arrow Articles by Kahri, A. I
Right arrow Search for Related Content
PubMed
Right arrow Articles by Liu, J.
Right arrow Articles by Kahri, A. I

Pheochromocytoma expressing adrenocorticotropin and corticotropin-releasing hormone; regulation by glucocorticoids and nerve growth factor

Jianqi Liu, Päivi Heikkilä, Raimo Voutilainen, Sirkka-Liisa Karonen and Arvi I Kahri

Liu J, Heikkilä P, Voutilainen R, Karonen S-L, Kahri AI, Pheochromocytoma expressing adrenocorticotropin and corticotropin-releasing hormone; regulation by glucocorticoids and nerve growth factor. Eur J Endocrinol 1994;131:221–8. ISSN 0804–4643

A pheochromocytoma from a 59-year-old woman was found to be immunoreactive to adrenocorticotropin (ACTH), chromogranin, neurofilament-200, neuron-specific enolase and S-100 protein. Northern blot analysis showed that both proopiomelanocortin (POMC) and corticotropin-releasing hormone (CRH) genes were expressed in the pheochromocytoma but not in the surrounding adrenal cortex. In primary culture, the POMC and CRH mRNAs were increased by dexamethasone (500 µg/l for 3 days) up to 10- and 15-fold of the control, respectively. The secretion of ACTH also was stimulated eightfold with the same treatment. The stimulatory effect of dexamethasone on POMC gene expression was inhibited 70% by nerve growth factor (NGF, 200 µg/l), 30% by 12-O-tetradecanoyl phorbol 13-acetate (TPA, 160 nmol/l) (a protein kinase-C activator) and 30% by (Bu)2cAMP (1 mmol/ 1). On the other hand, NGF alone increased the CRH mRNA accumulation up to 10-fold, and further enhanced the stimulatory effect of dexamethasone on the CRH mRNA twofold, and TPA inhibited (30%) the dexamethasone-induced CRH mRNA accumulation. Furthermore, the conditioned medium of the pheochromocytoma cells increased secretion of corticosterone fourfold in the primary culture of rat fetal adrenal cells. Our results indicate abnormal expression and regulation of POMC and CRH genes in this pheochromocytoma.

Arvi I Kahri, Department of Pathology, PO Box 21 (Haartmaninkatu 3), FIN-00014 University of Helsinki, Finland




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
A. L Rosas, A. A Kasperlik-Zaluska, L. Papierska, B. L. Bass, K. Pacak, and G. Eisenhofer
Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature
Eur. J. Endocrinol., March 1, 2008; 158(3): 423 - 429.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. White, D. W. Ray, A. Talbot, P. Abraham, A. J. Thody, and J. S. Bevan
Cushing's Syndrome Due to Phaeochromocytoma Secreting the Precursors of Adrenocorticotropin
J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4771 - 4775.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. Venihaki, K. Ain, E. Dermitzaki, A. Gravanis, and A. N. Margioris
KAT45, a Noradrenergic Human Pheochromocytoma Cell Line Producing Corticotropin-Releasing Hormone
Endocrinology, February 1, 1998; 139(2): 713 - 722.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Venihaki, A. Gravanis, and A. N. Margioris
Comparative Study between Normal Rat Chromaffin and PC12 Rat Pheochromocytoma Cells: Production and Effects of Corticotropin-Releasing Hormone
Endocrinology, February 1, 1997; 138(2): 698 - 704.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 European Society of Endocrinology.